Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Heinzel

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|October 26, 2019
Novel insights into non-HLA alloimmunity in kidney transplantationRoman Reindl-Schwaighofer, Andreas Heinzel, Guido A Gualdoni, et al.
Plos One|January 26, 2019
Synthetic lethality guiding selection of drug combinations in ovarian cancerAndreas Heinzel, Maximilian Marhold, Paul Mayer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicineHiddo J Lambers Heerspink, Rainer Oberbauer, Paul Perco, et al.
Diabetologia|April 20, 2019
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney diseaseHiddo J L Heerspink, Paul Perco, Skander Mulder, et al.
Oncotarget|December 18, 2018
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified <i>in silico</i> by genetic screens in yeastMaximilian Marhold, Erwin Tomasich, Michael Schwarz, et al.
Biodata Mining|July 17, 2015
Interaction networks for identifying coupled molecular processes in microbial communitiesMagnus Bosse, Alexander Heuwieser, Andreas Heinzel, et al.
Scientific Reports|May 5, 2018
Validation of systems biology derived molecular markers of renal donor organ status associated with long term allograft functionPaul Perco, Andreas Heinzel, Johannes Leierer, et al.
Frontiers in Immunology|March 14, 2022
Effects of Reduced-Dose Anti-Human T-Lymphocyte Globulin on Overall and Donor-Specific T-Cell Repertoire Reconstitution in Sensitized Kidney Transplant RecipientsConstantin Aschauer, Kira Jelencsics, Karin Hu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 8, 2019
Steroid pretreatment of organ donors does not impact on early rejection and long-term kidney allograft survival: Results from a multicenter randomized, controlled trialRoman Reindl-Schwaighofer, Alexander Kainz, Kira Jelencsics, et al.
Diagnostic and Prognostic Research|November 18, 2021
A prediction model for the decline in renal function in people with type 2 diabetes mellitus: study protocolMariella Gregorich, Andreas Heinzel, Michael Kammer, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
Transplant International : Official Journal of the European Society for Organ Transplantation|October 26, 2019
Novel insights into non-HLA alloimmunity in kidney transplantationRoman Reindl-Schwaighofer, Andreas Heinzel, Guido A Gualdoni, et al.
Plos One|January 26, 2019
Synthetic lethality guiding selection of drug combinations in ovarian cancerAndreas Heinzel, Maximilian Marhold, Paul Mayer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 26, 2015
Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicineHiddo J Lambers Heerspink, Rainer Oberbauer, Paul Perco, et al.
Diabetologia|April 20, 2019
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney diseaseHiddo J L Heerspink, Paul Perco, Skander Mulder, et al.
Oncotarget|December 18, 2018
Synthetic lethal combinations of low-toxicity drugs for breast cancer identified <i>in silico</i> by genetic screens in yeastMaximilian Marhold, Erwin Tomasich, Michael Schwarz, et al.
Biodata Mining|July 17, 2015
Interaction networks for identifying coupled molecular processes in microbial communitiesMagnus Bosse, Alexander Heuwieser, Andreas Heinzel, et al.
Scientific Reports|May 5, 2018
Validation of systems biology derived molecular markers of renal donor organ status associated with long term allograft functionPaul Perco, Andreas Heinzel, Johannes Leierer, et al.
Frontiers in Immunology|March 14, 2022
Effects of Reduced-Dose Anti-Human T-Lymphocyte Globulin on Overall and Donor-Specific T-Cell Repertoire Reconstitution in Sensitized Kidney Transplant RecipientsConstantin Aschauer, Kira Jelencsics, Karin Hu, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 8, 2019
Steroid pretreatment of organ donors does not impact on early rejection and long-term kidney allograft survival: Results from a multicenter randomized, controlled trialRoman Reindl-Schwaighofer, Alexander Kainz, Kira Jelencsics, et al.
Diagnostic and Prognostic Research|November 18, 2021
A prediction model for the decline in renal function in people with type 2 diabetes mellitus: study protocolMariella Gregorich, Andreas Heinzel, Michael Kammer, et al.
Pageof 8